Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05848791Completed

Assessing the Impact of Non-tailpipe Emissions From Traffic on the Asthmatic Airway

Role: collaborator

NCT00127062Not ApplicableCompleted

Health Effects of Diesel Exhaust in Asthmatic Patients: A Real-world Study in a London Street

Role: collaborator

NCT01487005Unknown

Cardiovascular Effects of Exposure to Ozone

Role: lead

NCT00922038Not ApplicableCompleted

Rewarding Sexually Transmitted Infection (STI) Prevention and Control in Tanzania

Role: collaborator

All 4 trials loaded